Roche Cobas H 232 POC System Kit

Additional information

Roche Cobas H 232 POC System Kit

The cobas h 232 is an in vitro diagnostic instrument intended for the quantitative evaluation of immunoassays using the Roche CARDIAC test strips in human whole blood. The cobas h 232 is intended for near-patient testing. Not for self-testing.

A portable point-of-care system that supports optimised management of patients with symptoms of chest pain and breathlessness by allowing confident on-the-spot decision diagnosis and assessment based on laboratory comparable results.

Allows rapid and easy determination of NT-proBNP, D-Dimer and Troponin T in different settings including Community Diagnostic Centres, GP practices, ambulances and emergency rooms.

• On-the-spot results are available in 3 steps and 12 minutes or less
• Handheld point of care system is lightweight and easy to use, even in mobile situation6,4
• Wireless technology ensures immediate availability of results at all Points of Care using the cobas® infinity POC solution4
• Accurate results, aligned with Roche central laboratory tests5
• Operator ID entry and lockout to ensure use by authorised staff
• Patient and user ID to ensure correct documentation of test results
• Quality control lockout
• Enhanced connectivity through wireless technology and a unique QR code feature can minimise errors, increase safety and streamline workflow
• Connection to the cobas® infinity POC solution allows extension of the testing network and ensures control of operators and quality assurance from the central laboratory
• Automatic recertification of operators through cobas academy to ensure use by trained operators only
• Results available in 8–12 minutes
• Rapid, on-the-spot decision support for treatment, referral, or discharge of cardiovascular patients
• Portable device which is suitable for use in the GP’s surgery, one stop clinics or community hospitals

Available tests:

Troponin: 40 – 2,000 ng/L
Roche CARDIAC POC Trop T with Results in 12 min
Early aid in diagnosis of acute myocardial infarction and identification of patients with an elevated mortality risk

NT-proBNP: 60 – 9,000 pg/mL
Roche CARDIAC proBNP+ with Results in 12 min
Aid in diagnosis of patients with suspected heart failure, in monitoring of patients with compensated left ventricular dysfunction and in the risk stratification of patients with acute coronary syndromes

D-Dimer: 0.1 - 4.0 µg/mL
Roche CARDIAC D-Dimer with Results in 8 min
Aid in exclusion of deep venousthrombosis